At the news
? NEUTRALIMPACT 3/10 144 filed Nov 9, 2026 at 16:36 ET
Ryan Savitz, an officer of Dianthus Therapeutics, filed a Form 144 notice of intent to sell 124,042 shares of common stock, with an approximate market value of $10.7 million based on the filing. The shares are to be acquired through the exercise of stock options over the next three months. This represents a notable insider sale relative to the company's $4.7B market cap.
- Filer: Ryan Savitz, an officer of Dianthus Therapeutics
- Shares to be sold: 124,042 shares of common stock
- Approximate market value: $10,671,333.26
- Shares to be acquired via exercise of stock options over the next three months
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access